Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 50268-628

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50268-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 5026862715 Oxybutynin Chloride Er 2014 5mg

This is a description of the medication "Oxybutynin Chloride" in extended-release form, available in a pack of 50 tablets per unit dose. The NDC number is 50268.627-45. However, the text contains errors and some parts are not readable.*

FDA Label Image

Label 5026862815 Oxybutynin Chloride Er 2017 10mg

This is a prescription medication with NDC number 50268-628-15. The medication is Oxybutynin Chloride which comes in extended-release tablets form with 10mg of oxybutynin chloride in each tablet. The usual dosage is once daily and dosage information can be found on the package insert. This particular package contains 50 tablets in unit dose form. It should be stored at room temperature (15°-30°C) and protected from moisture and humidity. This product was manufactured by Avkare and should be kept out of the reach of children.*

FDA Label Image

Label 5026862913 Oxybutynin Chloride Er 2014 15mg

FDA Label Image

Structural Formula (Oxybutynin 1)

FDA Label Image

Mean Plasma Levels (Oxybutynin 2)

Oxbutynin chloride extended-release tablets are a medication that is commonly used to treat certain bladder and urinary conditions. It works by relaxing the muscles in the bladder, thereby reducing instances of incontinence and other associated symptoms. This medication comes in the form of prolonged-release tablets that slowly release the medication over a set period of time, helping to maintain consistent levels of medication in the body for optimal treatment effectiveness.*

FDA Label Image

Steady State (Oxybutynin 3)

FDA Label Image

Study 1 (Oxybutynin 4)

FDA Label Image

Study 2 (Oxybutynin 5)

FDA Label Image

Study 3 (Oxybutynin 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.